Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16
- PMID: 10073701
- DOI: 10.1099/0022-1317-80-2-409
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16
Abstract
To investigate whether there is an association between local or systemic IgG and IgA responses against human papillomavirus (HPV) type 16 virus-like particles (VLP) containing L1 and L2 and the possible influence of these responses on clearance of HPV-16 and its associated lesions, cervical mucus samples from 125 patients and plasma samples from 100 patients, all participating in a non-intervention cohort study of women with abnormal cytology, were analysed. The results show that local IgG and IgA HPV-16 VLP-specific antibodies do not correlate with virus clearance. However, systemic IgG responses were more frequently detected in patients with a persistent infection (11/24) compared with patients with cleared HPV-16 infections (3/28, P = 0.006). Furthermore, the ultimate development of high-grade lesions was associated with systemic VLP-specific IgG reactivity (P = 0.026). By contrast, systemic IgA responses were correlated with virus clearance (7/28 clearance compared with 1/24 persistence patients, P = 0.06). This correlation was statistically significant when only those clearance patients who tested HPV-16 DNA-positive at more than one visit were included in the analysis (5/11 compared with 1/24, P = 0.007). As these systemic IgA responses were not accompanied by local IgA responses, the systemic IgA responses in HPV-16 clearance patients are suggested to be a by-product of a successful cellular immune response induced at the local lymph nodes, mediated by cytokines.
Similar articles
-
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.J Gen Virol. 1999 Feb;80 ( Pt 2):399-408. doi: 10.1099/0022-1317-80-2-399. J Gen Virol. 1999. PMID: 10073700
-
Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.J Natl Cancer Inst. 1997 May 7;89(9):630-8. doi: 10.1093/jnci/89.9.630. J Natl Cancer Inst. 1997. PMID: 9150187
-
Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.Clin Diagn Lab Immunol. 1996 Jul;3(4):403-10. doi: 10.1128/cdli.3.4.403-410.1996. Clin Diagn Lab Immunol. 1996. PMID: 8807204 Free PMC article.
-
Developments in L2-based human papillomavirus (HPV) vaccines.Virus Res. 2017 Mar 2;231:166-175. doi: 10.1016/j.virusres.2016.11.020. Epub 2016 Nov 23. Virus Res. 2017. PMID: 27889616 Free PMC article. Review.
-
Immunity to oncogenic human papillomaviruses.Adv Cancer Res. 2001;82:205-38. doi: 10.1016/s0065-230x(01)82007-8. Adv Cancer Res. 2001. PMID: 11447764 Review.
Cited by
-
Use of the normalized absorbance ratio as an internal standardization approach to minimize measurement error in enzyme-linked immunosorbent assays for diagnosis of human papillomavirus infection.J Clin Microbiol. 2010 Mar;48(3):791-6. doi: 10.1128/JCM.00844-09. Epub 2010 Jan 6. J Clin Microbiol. 2010. PMID: 20053861 Free PMC article.
-
Serum and cervicovaginal IgG immune responses against α7 and α9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination.PLoS One. 2020 May 18;15(5):e0233084. doi: 10.1371/journal.pone.0233084. eCollection 2020. PLoS One. 2020. PMID: 32421735 Free PMC article.
-
Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination.Hum Vaccin Immunother. 2013 Feb;9(2):314-21. doi: 10.4161/hv.22693. Epub 2012 Nov 13. Hum Vaccin Immunother. 2013. PMID: 23149693 Free PMC article.
-
Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women.J Clin Microbiol. 2008 Feb;46(2):732-9. doi: 10.1128/JCM.01322-07. Epub 2007 Dec 12. J Clin Microbiol. 2008. PMID: 18077644 Free PMC article.
-
Perceived stress is associated with impaired T-cell response to HPV16 in women with cervical dysplasia.Ann Behav Med. 2008 Feb;35(1):87-96. doi: 10.1007/s12160-007-9007-6. Epub 2008 Feb 13. Ann Behav Med. 2008. PMID: 18347908 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous